Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfatc3
|
ENSMUSG00000031902.9 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_106058583_106058734 | Nfatc3 | 182 | 0.903268 | 0.56 | 2.7e-06 | Click! |
chr8_106054482_106054922 | Nfatc3 | 4138 | 0.122012 | 0.53 | 1.5e-05 | Click! |
chr8_106058802_106059422 | Nfatc3 | 272 | 0.844947 | 0.53 | 1.6e-05 | Click! |
chr8_106060912_106061063 | Nfatc3 | 1354 | 0.284274 | 0.51 | 3.0e-05 | Click! |
chr8_106060726_106060877 | Nfatc3 | 1168 | 0.329587 | 0.40 | 1.5e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_143825863_143827628 | 5.15 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr19_20389423_20390852 | 4.22 |
Anxa1 |
annexin A1 |
514 |
0.81 |
chr1_162217585_162219370 | 3.18 |
Dnm3os |
dynamin 3, opposite strand |
601 |
0.46 |
chr19_34253411_34255499 | 3.14 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
225 |
0.92 |
chr6_135362982_135365483 | 3.02 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr8_57319308_57320679 | 2.95 |
Hand2os1 |
Hand2, opposite strand 1 |
63 |
0.94 |
chr3_30010716_30011762 | 2.95 |
Mecom |
MDS1 and EVI1 complex locus |
200 |
0.91 |
chr8_36951282_36952693 | 2.83 |
Dlc1 |
deleted in liver cancer 1 |
370 |
0.88 |
chr10_60828323_60829684 | 2.77 |
Unc5b |
unc-5 netrin receptor B |
2379 |
0.28 |
chr10_5287995_5289689 | 2.75 |
Gm23573 |
predicted gene, 23573 |
68331 |
0.12 |
chr18_60646910_60648302 | 2.74 |
Synpo |
synaptopodin |
666 |
0.69 |
chr15_99818282_99820126 | 2.69 |
Gm17057 |
predicted gene 17057 |
184 |
0.83 |
chr2_84423814_84425562 | 2.66 |
Calcrl |
calcitonin receptor-like |
578 |
0.75 |
chr18_11049995_11051717 | 2.58 |
Gata6os |
GATA binding protein 6, opposite strand |
631 |
0.64 |
chr12_103434225_103434651 | 2.50 |
Ifi27 |
interferon, alpha-inducible protein 27 |
146 |
0.91 |
chr8_85362205_85362356 | 2.40 |
Mylk3 |
myosin light chain kinase 3 |
3044 |
0.18 |
chr2_62572999_62574382 | 2.39 |
Fap |
fibroblast activation protein |
130 |
0.97 |
chr10_8944239_8945864 | 2.38 |
Gm48728 |
predicted gene, 48728 |
6898 |
0.2 |
chr8_67949354_67949997 | 2.35 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
2204 |
0.34 |
chr3_79885722_79887545 | 2.33 |
Gm36569 |
predicted gene, 36569 |
173 |
0.83 |
chr10_93347628_93348351 | 2.28 |
Gm17745 |
predicted gene, 17745 |
12596 |
0.16 |
chr18_60963604_60964955 | 2.17 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
679 |
0.59 |
chr2_76981844_76982498 | 2.14 |
Ttn |
titin |
284 |
0.93 |
chr1_55225274_55225752 | 2.12 |
Gm10561 |
predicted gene 10561 |
738 |
0.49 |
chr12_33960516_33961726 | 2.11 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
3450 |
0.27 |
chr3_144759885_144761021 | 2.11 |
Clca3a1 |
chloride channel accessory 3A1 |
388 |
0.78 |
chr10_53340367_53340889 | 2.09 |
Pln |
phospholamban |
2923 |
0.17 |
chr8_108027187_108028441 | 2.08 |
Zfhx3 |
zinc finger homeobox 3 |
33255 |
0.23 |
chr8_57326741_57329467 | 2.06 |
Hand2os1 |
Hand2, opposite strand 1 |
3871 |
0.15 |
chr10_76621571_76623890 | 2.05 |
Col6a2 |
collagen, type VI, alpha 2 |
595 |
0.68 |
chr6_136855871_136856717 | 2.04 |
Art4 |
ADP-ribosyltransferase 4 |
1439 |
0.23 |
chr1_45312700_45313452 | 2.04 |
Gm47302 |
predicted gene, 47302 |
1403 |
0.35 |
chr7_142662290_142664788 | 2.02 |
Igf2os |
insulin-like growth factor 2, opposite strand |
1599 |
0.21 |
chrX_52609355_52610313 | 1.98 |
Gpc3 |
glypican 3 |
4087 |
0.23 |
chrX_52610922_52611739 | 1.96 |
Gpc3 |
glypican 3 |
2591 |
0.28 |
chr13_63241575_63242090 | 1.92 |
Aopep |
aminopeptidase O |
1724 |
0.2 |
chr12_101817155_101817772 | 1.88 |
Fbln5 |
fibulin 5 |
1005 |
0.56 |
chr10_126144533_126145092 | 1.87 |
Gm4510 |
predicted gene 4510 |
41511 |
0.18 |
chr3_95498942_95500401 | 1.82 |
Ctsk |
cathepsin K |
415 |
0.72 |
chr5_119673183_119673803 | 1.82 |
Tbx3 |
T-box 3 |
1952 |
0.23 |
chr3_19645245_19645748 | 1.82 |
Trim55 |
tripartite motif-containing 55 |
988 |
0.49 |
chr2_80037645_80038971 | 1.81 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
721 |
0.79 |
chr7_142654280_142656231 | 1.79 |
Mir483 |
microRNA 483 |
259 |
0.76 |
chrX_142683568_142684227 | 1.74 |
Tmem164 |
transmembrane protein 164 |
1009 |
0.56 |
chr8_45886169_45886353 | 1.74 |
Pdlim3 |
PDZ and LIM domain 3 |
741 |
0.57 |
chr3_102526069_102526911 | 1.72 |
Gm42679 |
predicted gene 42679 |
35148 |
0.14 |
chr4_98925464_98925615 | 1.71 |
Usp1 |
ubiquitin specific peptidase 1 |
1575 |
0.38 |
chr13_89542286_89542958 | 1.70 |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
2826 |
0.34 |
chr5_102724663_102726037 | 1.69 |
Arhgap24 |
Rho GTPase activating protein 24 |
377 |
0.93 |
chr8_119490510_119491264 | 1.69 |
Slc38a8 |
solute carrier family 38, member 8 |
4008 |
0.17 |
chr8_57324709_57326732 | 1.69 |
Hand2os1 |
Hand2, opposite strand 1 |
1487 |
0.3 |
chr3_145991092_145991594 | 1.68 |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
2328 |
0.28 |
chr5_53469318_53470522 | 1.67 |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
3768 |
0.25 |
chr17_81737002_81738450 | 1.66 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
651 |
0.81 |
chr8_45661677_45662126 | 1.65 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
92 |
0.97 |
chr12_117657998_117660727 | 1.64 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr4_43520861_43521689 | 1.63 |
Tpm2 |
tropomyosin 2, beta |
1606 |
0.17 |
chr16_45093540_45095213 | 1.63 |
Ccdc80 |
coiled-coil domain containing 80 |
323 |
0.91 |
chr15_77202074_77202631 | 1.63 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
1084 |
0.46 |
chr2_110360491_110361293 | 1.63 |
Fibin |
fin bud initiation factor homolog (zebrafish) |
2291 |
0.34 |
chr14_20478404_20479012 | 1.62 |
Anxa7 |
annexin A7 |
1200 |
0.35 |
chr17_49562986_49564570 | 1.62 |
Daam2 |
dishevelled associated activator of morphogenesis 2 |
528 |
0.84 |
chr9_32224792_32225293 | 1.62 |
Arhgap32 |
Rho GTPase activating protein 32 |
450 |
0.85 |
chr5_119838900_119840891 | 1.61 |
Tbx5 |
T-box 5 |
3740 |
0.21 |
chr4_86055007_86055578 | 1.60 |
Adamtsl1 |
ADAMTS-like 1 |
1272 |
0.55 |
chr7_82425238_82425812 | 1.59 |
Adamtsl3 |
ADAMTS-like 3 |
17051 |
0.23 |
chr3_152264546_152264733 | 1.58 |
Nexn |
nexilin |
1128 |
0.39 |
chr15_103242280_103243411 | 1.57 |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
2351 |
0.16 |
chr8_105593743_105594653 | 1.57 |
Gm45855 |
predicted gene 45855 |
7998 |
0.08 |
chr5_64599895_64600712 | 1.57 |
Gm3716 |
predicted gene 3716 |
2857 |
0.18 |
chr10_61920176_61921089 | 1.57 |
Gm5750 |
predicted gene 5750 |
38992 |
0.14 |
chr9_84113968_84114740 | 1.55 |
Bckdhb |
branched chain ketoacid dehydrogenase E1, beta polypeptide |
6847 |
0.26 |
chr14_16572461_16573738 | 1.54 |
Rarb |
retinoic acid receptor, beta |
1946 |
0.34 |
chr13_63273798_63275383 | 1.54 |
Gm47585 |
predicted gene, 47585 |
990 |
0.28 |
chr2_158145151_158146425 | 1.54 |
Tgm2 |
transglutaminase 2, C polypeptide |
578 |
0.71 |
chr6_52255456_52256182 | 1.51 |
9530018H14Rik |
RIKEN cDNA 9530018H14 gene |
1641 |
0.14 |
chr18_4995747_4996610 | 1.51 |
Svil |
supervillin |
1242 |
0.62 |
chr7_142576289_142578620 | 1.51 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr2_84936571_84938205 | 1.50 |
Slc43a3 |
solute carrier family 43, member 3 |
498 |
0.71 |
chr13_34725859_34726844 | 1.49 |
Gm47151 |
predicted gene, 47151 |
5600 |
0.13 |
chr7_75613990_75614480 | 1.48 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
453 |
0.84 |
chr16_57551520_57552150 | 1.47 |
Filip1l |
filamin A interacting protein 1-like |
2593 |
0.35 |
chr10_33085602_33085934 | 1.46 |
Trdn |
triadin |
2207 |
0.39 |
chr7_83881977_83882131 | 1.46 |
Tlnrd1 |
talin rod domain containing 1 |
2251 |
0.16 |
chr16_72217789_72218152 | 1.46 |
8030451O07Rik |
RIKEN cDNA 8030451O07 gene |
16332 |
0.28 |
chr11_111068351_111069422 | 1.46 |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
2722 |
0.38 |
chr2_57997628_57998772 | 1.45 |
Galnt5 |
polypeptide N-acetylgalactosaminyltransferase 5 |
316 |
0.9 |
chr9_64017614_64019400 | 1.45 |
Smad6 |
SMAD family member 6 |
1520 |
0.33 |
chr3_102086617_102087454 | 1.44 |
Casq2 |
calsequestrin 2 |
396 |
0.81 |
chr12_27060576_27062882 | 1.43 |
Gm9866 |
predicted gene 9866 |
53266 |
0.17 |
chr6_4005045_4005321 | 1.43 |
Gng11 |
guanine nucleotide binding protein (G protein), gamma 11 |
1279 |
0.41 |
chr4_144404354_144405079 | 1.43 |
Pramef12os |
PRAME family member 12, opposite strand |
152 |
0.91 |
chr11_85832611_85833034 | 1.43 |
Tbx2 |
T-box 2 |
271 |
0.72 |
chr2_114054589_114054921 | 1.42 |
C130080G10Rik |
RIKEN cDNA C130080G10 gene |
359 |
0.79 |
chr13_89540278_89541317 | 1.42 |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
1001 |
0.64 |
chr3_102470983_102471197 | 1.42 |
Ngf |
nerve growth factor |
1162 |
0.5 |
chr10_56468695_56469687 | 1.41 |
Gm9118 |
predicted gene 9118 |
28150 |
0.16 |
chr3_58419356_58419775 | 1.41 |
Tsc22d2 |
TSC22 domain family, member 2 |
2081 |
0.31 |
chr3_58420033_58420589 | 1.40 |
Tsc22d2 |
TSC22 domain family, member 2 |
2827 |
0.26 |
chr11_83065104_83067047 | 1.39 |
Slfn2 |
schlafen 2 |
963 |
0.31 |
chr16_95618168_95618511 | 1.39 |
Erg |
ETS transcription factor |
31746 |
0.2 |
chr8_85429490_85430057 | 1.39 |
1700051O22Rik |
RIKEN cDNA 1700051O22 Gene |
2913 |
0.17 |
chr5_119841347_119842608 | 1.39 |
Tbx5 |
T-box 5 |
5822 |
0.19 |
chr12_36317748_36317957 | 1.39 |
Sostdc1 |
sclerostin domain containing 1 |
3713 |
0.19 |
chr10_58394969_58395625 | 1.39 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
909 |
0.6 |
chr18_61952844_61953759 | 1.38 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
217 |
0.94 |
chr5_32137024_32137228 | 1.38 |
Fosl2 |
fos-like antigen 2 |
953 |
0.5 |
chr3_100921543_100921984 | 1.38 |
Trim45 |
tripartite motif-containing 45 |
439 |
0.82 |
chr4_120813489_120813640 | 1.37 |
Nfyc |
nuclear transcription factor-Y gamma |
2148 |
0.21 |
chrX_50844122_50844462 | 1.37 |
Stk26 |
serine/threonine kinase 26 |
2851 |
0.37 |
chr10_69925300_69927130 | 1.37 |
Ank3 |
ankyrin 3, epithelial |
82 |
0.99 |
chr14_25397115_25397717 | 1.37 |
Gm26660 |
predicted gene, 26660 |
17807 |
0.16 |
chr7_89405888_89406433 | 1.37 |
Fzd4 |
frizzled class receptor 4 |
1805 |
0.24 |
chr13_94709555_94711133 | 1.35 |
Gm32351 |
predicted gene, 32351 |
7626 |
0.16 |
chrX_21485587_21486692 | 1.35 |
Agtr2 |
angiotensin II receptor, type 2 |
1417 |
0.41 |
chr6_48705812_48706743 | 1.34 |
Gimap6 |
GTPase, IMAP family member 6 |
41 |
0.93 |
chr3_36476762_36476913 | 1.33 |
1810062G17Rik |
RIKEN cDNA 1810062G17 gene |
900 |
0.29 |
chr13_89541543_89541900 | 1.33 |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
1925 |
0.42 |
chr1_188660237_188661369 | 1.33 |
Gm25095 |
predicted gene, 25095 |
37750 |
0.21 |
chr12_83922085_83922734 | 1.33 |
Numb |
NUMB endocytic adaptor protein |
475 |
0.71 |
chr3_30507006_30507402 | 1.32 |
Mecom |
MDS1 and EVI1 complex locus |
2283 |
0.22 |
chr11_117825178_117825853 | 1.32 |
Tk1 |
thymidine kinase 1 |
302 |
0.53 |
chr7_16993892_16995169 | 1.32 |
Ccdc8 |
coiled-coil domain containing 8 |
1822 |
0.2 |
chr16_76679845_76680911 | 1.31 |
Gm45029 |
predicted gene 45029 |
135 |
0.97 |
chr17_70847820_70848429 | 1.31 |
Tgif1 |
TGFB-induced factor homeobox 1 |
954 |
0.38 |
chr8_77722901_77723292 | 1.31 |
4933431K23Rik |
RIKEN cDNA 4933431K23 gene |
488 |
0.72 |
chr19_53145040_53145459 | 1.31 |
Add3 |
adducin 3 (gamma) |
1252 |
0.37 |
chr7_141009744_141010714 | 1.31 |
Ifitm3 |
interferon induced transmembrane protein 3 |
541 |
0.54 |
chr4_106804374_106805428 | 1.30 |
Acot11 |
acyl-CoA thioesterase 11 |
97 |
0.96 |
chr10_93294354_93295420 | 1.29 |
Elk3 |
ELK3, member of ETS oncogene family |
15924 |
0.16 |
chr13_99238375_99238526 | 1.29 |
Zfp366 |
zinc finger protein 366 |
53627 |
0.12 |
chr11_120948479_120950230 | 1.28 |
Slc16a3 |
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
273 |
0.84 |
chr4_114688181_114688818 | 1.28 |
Gm12829 |
predicted gene 12829 |
7695 |
0.22 |
chr5_30913519_30915234 | 1.27 |
Emilin1 |
elastin microfibril interfacer 1 |
637 |
0.48 |
chr8_84202337_84202869 | 1.27 |
Gm37352 |
predicted gene, 37352 |
1734 |
0.12 |
chr6_124512631_124513557 | 1.26 |
C1ra |
complement component 1, r subcomponent A |
689 |
0.5 |
chr1_133800027_133801076 | 1.25 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
485 |
0.75 |
chr13_35383370_35383724 | 1.25 |
Gm48703 |
predicted gene, 48703 |
11836 |
0.24 |
chr3_127123282_127124895 | 1.24 |
Ank2 |
ankyrin 2, brain |
774 |
0.59 |
chr1_51288641_51290950 | 1.24 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr3_116806554_116807301 | 1.24 |
Agl |
amylo-1,6-glucosidase, 4-alpha-glucanotransferase |
490 |
0.71 |
chr1_157506653_157507518 | 1.24 |
Sec16b |
SEC16 homolog B (S. cerevisiae) |
275 |
0.89 |
chr2_103600352_103600727 | 1.24 |
Abtb2 |
ankyrin repeat and BTB (POZ) domain containing 2 |
34229 |
0.15 |
chr16_87246194_87246671 | 1.23 |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
107753 |
0.06 |
chr9_69454872_69455904 | 1.23 |
Anxa2 |
annexin A2 |
1322 |
0.26 |
chrX_53055829_53057122 | 1.23 |
C430049B03Rik |
RIKEN cDNA C430049B03 gene |
685 |
0.41 |
chr2_35557994_35559313 | 1.22 |
Gm13446 |
predicted gene 13446 |
49 |
0.85 |
chr7_83745073_83746180 | 1.22 |
Il16 |
interleukin 16 |
100 |
0.95 |
chr16_44239037_44239393 | 1.22 |
Sidt1 |
SID1 transmembrane family, member 1 |
30317 |
0.17 |
chr14_121450803_121451246 | 1.22 |
Gm33299 |
predicted gene, 33299 |
4738 |
0.21 |
chr13_63250847_63251888 | 1.21 |
Gm47603 |
predicted gene, 47603 |
4197 |
0.11 |
chr12_33175613_33176774 | 1.21 |
Atxn7l1 |
ataxin 7-like 1 |
28388 |
0.14 |
chr9_45042261_45043690 | 1.21 |
Mpzl2 |
myelin protein zero-like 2 |
279 |
0.8 |
chr17_43362301_43362937 | 1.21 |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
2168 |
0.39 |
chr3_49753928_49755610 | 1.21 |
Pcdh18 |
protocadherin 18 |
695 |
0.72 |
chr9_72448745_72450029 | 1.19 |
Gm27231 |
predicted gene 27231 |
7608 |
0.08 |
chr2_101649005_101649668 | 1.18 |
Rag1 |
recombination activating 1 |
165 |
0.54 |
chr2_164442047_164443132 | 1.18 |
Sdc4 |
syndecan 4 |
597 |
0.53 |
chr18_61045132_61047010 | 1.18 |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
871 |
0.5 |
chr7_67647422_67648404 | 1.18 |
Ttc23 |
tetratricopeptide repeat domain 23 |
453 |
0.74 |
chr7_142661369_142661520 | 1.18 |
Igf2 |
insulin-like growth factor 2 |
139 |
0.91 |
chr2_4560599_4561970 | 1.17 |
Frmd4a |
FERM domain containing 4A |
1509 |
0.43 |
chr5_113799288_113800716 | 1.17 |
Tmem119 |
transmembrane protein 119 |
444 |
0.69 |
chr1_71649541_71649936 | 1.17 |
Apol7d |
apolipoprotein L 7d |
3099 |
0.23 |
chr9_75231636_75232704 | 1.17 |
Myo5c |
myosin VC |
94 |
0.97 |
chr15_39078038_39078699 | 1.17 |
Cthrc1 |
collagen triple helix repeat containing 1 |
1287 |
0.33 |
chr13_106835269_106836682 | 1.16 |
Lrrc70 |
leucine rich repeat containing 70 |
173 |
0.7 |
chr17_5849319_5850025 | 1.16 |
Snx9 |
sorting nexin 9 |
8320 |
0.15 |
chr7_68917284_68917934 | 1.16 |
Gm34664 |
predicted gene, 34664 |
1593 |
0.45 |
chr5_75975825_75977229 | 1.16 |
Kdr |
kinase insert domain protein receptor |
1931 |
0.31 |
chr9_67832082_67832627 | 1.16 |
C2cd4a |
C2 calcium-dependent domain containing 4A |
24 |
0.98 |
chrX_145503014_145503702 | 1.16 |
Amot |
angiomotin |
1786 |
0.47 |
chr15_66892766_66893452 | 1.16 |
Ccn4 |
cellular communication network factor 4 |
1601 |
0.37 |
chr6_4483924_4484443 | 1.16 |
Gm37883 |
predicted gene, 37883 |
15 |
0.97 |
chr14_73237952_73239675 | 1.16 |
Lpar6 |
lysophosphatidic acid receptor 6 |
918 |
0.38 |
chr15_35300811_35301759 | 1.16 |
Osr2 |
odd-skipped related 2 |
985 |
0.56 |
chr2_30463308_30464400 | 1.15 |
Ier5l |
immediate early response 5-like |
10365 |
0.13 |
chrX_82949777_82950054 | 1.15 |
Dmd |
dystrophin, muscular dystrophy |
1012 |
0.71 |
chr13_3891572_3893506 | 1.15 |
Net1 |
neuroepithelial cell transforming gene 1 |
894 |
0.46 |
chr19_53679904_53680339 | 1.15 |
Rbm20 |
RNA binding motif protein 20 |
2815 |
0.26 |
chr14_23786398_23786671 | 1.14 |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
16770 |
0.27 |
chr6_21988159_21989249 | 1.14 |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
1812 |
0.42 |
chr2_73484519_73485212 | 1.14 |
Wipf1 |
WAS/WASL interacting protein family, member 1 |
898 |
0.55 |
chr2_72620037_72620883 | 1.14 |
Pex13-ps |
peroxisomal biogenesis factor 13, pseudogene |
11810 |
0.17 |
chr7_100911201_100912201 | 1.13 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
17011 |
0.13 |
chr6_97311036_97312726 | 1.13 |
Frmd4b |
FERM domain containing 4B |
499 |
0.83 |
chr2_74678970_74680401 | 1.13 |
Hoxd11 |
homeobox D11 |
128 |
0.86 |
chr12_9573836_9576858 | 1.12 |
Osr1 |
odd-skipped related transcription factor 1 |
906 |
0.56 |
chr10_4611597_4612860 | 1.12 |
Esr1 |
estrogen receptor 1 (alpha) |
207 |
0.95 |
chr6_92533537_92534212 | 1.12 |
Prickle2 |
prickle planar cell polarity protein 2 |
987 |
0.63 |
chr8_62284047_62284979 | 1.11 |
Gm2961 |
predicted gene 2961 |
90301 |
0.09 |
chr8_106510659_106512038 | 1.11 |
Cdh3 |
cadherin 3 |
457 |
0.8 |
chr10_100741944_100742338 | 1.10 |
Gm35722 |
predicted gene, 35722 |
506 |
0.85 |
chr15_93824709_93825690 | 1.10 |
Gm49445 |
predicted gene, 49445 |
161 |
0.97 |
chr18_69084174_69085263 | 1.10 |
Mir145b |
microRNA 145b |
62445 |
0.11 |
chr6_53290295_53290911 | 1.09 |
Creb5 |
cAMP responsive element binding protein 5 |
180 |
0.97 |
chr16_85797660_85797940 | 1.09 |
Adamts1 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 |
1838 |
0.41 |
chr7_49523484_49523693 | 1.09 |
Nav2 |
neuron navigator 2 |
24604 |
0.22 |
chr15_11398667_11398818 | 1.08 |
Tars |
threonyl-tRNA synthetase |
859 |
0.7 |
chr3_121969276_121969790 | 1.08 |
Arhgap29 |
Rho GTPase activating protein 29 |
1704 |
0.38 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.1 | 3.4 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.1 | 4.5 | GO:0003166 | bundle of His development(GO:0003166) |
0.9 | 2.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.9 | 2.6 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.8 | 0.8 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.8 | 2.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.8 | 0.8 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.7 | 2.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.7 | 2.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.7 | 2.8 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.6 | 1.9 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.6 | 1.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.6 | 1.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 3.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.6 | 2.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 3.0 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.6 | 1.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.5 | 1.6 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.5 | 2.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 3.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 2.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 2.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.5 | 1.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.5 | 1.0 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.5 | 1.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.5 | 1.4 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.5 | 0.5 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.5 | 1.4 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.5 | 1.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.5 | 2.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.5 | 1.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.5 | 2.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.5 | 2.3 | GO:0003175 | tricuspid valve development(GO:0003175) |
0.5 | 1.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.5 | 2.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.5 | 1.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.5 | 0.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 0.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.5 | 2.7 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.4 | 1.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 1.3 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.4 | 0.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 1.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.4 | 1.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 1.7 | GO:0070836 | caveola assembly(GO:0070836) |
0.4 | 1.3 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.4 | 0.8 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.4 | 1.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 1.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 4.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 1.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.4 | 0.8 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.4 | 2.4 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.4 | 1.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.4 | 3.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.4 | 1.9 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 0.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.4 | 0.7 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.4 | 0.7 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.4 | 0.4 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.4 | 1.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.4 | 1.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 1.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.3 | 1.4 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.3 | 1.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 1.0 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 2.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.3 | 1.3 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.3 | 1.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 1.6 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 0.7 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.3 | 0.6 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 1.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.9 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 1.9 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.3 | 0.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.3 | 1.2 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 0.3 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.3 | 0.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 0.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 0.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 0.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 0.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.3 | 1.5 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 0.6 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.3 | 0.9 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 1.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 4.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.3 | 0.6 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.3 | 1.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 0.3 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.3 | 0.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.6 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.3 | 0.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 0.8 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 1.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 1.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.3 | 0.8 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.3 | 0.8 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.3 | 1.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.5 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.3 | 0.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.3 | 0.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 0.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.3 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 0.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 1.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 3.8 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 2.2 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.2 | 1.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 1.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 2.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 1.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 0.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 1.0 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.2 | 0.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.2 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.2 | 3.1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.2 | 0.7 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.5 | GO:0035932 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.2 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.7 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 1.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 2.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 0.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.7 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 1.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.7 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 0.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 1.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.2 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 1.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 1.3 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.5 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.6 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.2 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.4 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.2 | 0.8 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.2 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.6 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 0.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 0.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.2 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 0.8 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 1.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.6 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.8 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.2 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 0.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 1.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 0.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 2.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.6 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) |
0.2 | 0.6 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 0.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 1.2 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 1.2 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.2 | 0.8 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.8 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 0.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 0.9 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 1.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.6 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.6 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 0.6 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 1.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.2 | 1.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 1.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.4 | GO:0033092 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.4 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.2 | 0.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 4.9 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 1.8 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.2 | 0.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.9 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.2 | 0.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 2.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 0.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 0.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.2 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.2 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.2 | 0.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.2 | 0.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.2 | 0.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 1.7 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.2 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.2 | 1.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.3 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.2 | 0.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.5 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 1.2 | GO:2001212 | regulation of vasculogenesis(GO:2001212) positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.2 | 0.3 | GO:0072033 | ureteric bud elongation(GO:0060677) renal vesicle formation(GO:0072033) |
0.2 | 1.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 1.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.2 | 0.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 0.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 3.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 1.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 0.5 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.2 | 0.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 4.5 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.2 | 0.8 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.2 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 0.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 0.3 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 0.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.2 | 0.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 0.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.3 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.2 | 0.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.2 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.2 | 0.5 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.2 | 0.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.2 | 1.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 0.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.3 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 0.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.2 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.2 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.5 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 0.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 0.6 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 2.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 1.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.6 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.7 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.6 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.3 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) axial mesoderm formation(GO:0048320) |
0.1 | 2.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 1.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.3 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 1.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.9 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 1.3 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.4 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 0.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 2.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 1.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 1.7 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.3 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.1 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 0.3 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.1 | 0.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.3 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.1 | 0.4 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.3 | GO:0070170 | regulation of tooth mineralization(GO:0070170) positive regulation of tooth mineralization(GO:0070172) |
0.1 | 1.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.7 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.8 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 1.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 1.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 0.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 1.5 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.3 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 1.4 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.6 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 1.1 | GO:0072413 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 1.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 1.0 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.4 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.2 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.1 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 1.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.1 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.1 | 1.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 1.6 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.7 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.5 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 1.9 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.4 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.1 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.5 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 0.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 1.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 1.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.1 | GO:0072143 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.1 | 1.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.7 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 1.6 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.3 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.1 | 0.2 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 1.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.3 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.9 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.1 | 0.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.2 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.3 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.1 | 0.6 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 1.3 | GO:0055006 | cardiac cell development(GO:0055006) |
0.1 | 0.5 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.4 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.6 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.1 | 2.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.9 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.2 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 1.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.4 | GO:0001781 | neutrophil apoptotic process(GO:0001781) negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.4 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.1 | 0.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 5.1 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.3 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 1.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.1 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.1 | 0.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.2 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.1 | 0.2 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 1.0 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.5 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.1 | GO:0070586 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.1 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.3 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.1 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.1 | 0.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.4 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.3 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.5 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.3 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.3 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.1 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.4 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 0.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 1.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 1.6 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 1.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 0.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.2 | GO:0055094 | response to lipoprotein particle(GO:0055094) response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.2 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.2 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.1 | 0.2 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.1 | 0.6 | GO:0071548 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.1 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.2 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.4 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.2 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 1.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.7 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.2 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.2 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.7 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 1.0 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.6 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.9 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 1.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 1.0 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
0.1 | 0.1 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.2 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 1.7 | GO:0035904 | aorta development(GO:0035904) |
0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.2 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.4 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.9 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.4 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.2 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.1 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.6 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 1.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.2 | GO:1901380 | negative regulation of potassium ion transmembrane transport(GO:1901380) |
0.1 | 0.1 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.1 | 0.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.3 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.1 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.3 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.3 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.7 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.1 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 2.3 | GO:0060021 | palate development(GO:0060021) |
0.1 | 0.3 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.5 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.3 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.4 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.2 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.7 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.3 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 1.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.3 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.2 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.3 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.4 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.1 | 0.1 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.1 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.1 | 0.1 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.2 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.1 | 0.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.8 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.1 | 0.1 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.9 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.3 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.5 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.1 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.1 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.1 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.6 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.4 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.6 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.6 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.5 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.1 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.1 | 0.2 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.2 | GO:0060405 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.1 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.6 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.1 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.6 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.4 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.1 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.1 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.2 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
0.1 | 0.8 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.2 | GO:0031579 | membrane raft organization(GO:0031579) |
0.1 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.9 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.5 | GO:0010658 | striated muscle cell apoptotic process(GO:0010658) |
0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.6 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.3 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.1 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.1 | GO:0085020 | protein K27-linked ubiquitination(GO:0044314) protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.3 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.1 | 0.3 | GO:0051299 | mitotic centrosome separation(GO:0007100) centrosome separation(GO:0051299) |
0.1 | 0.1 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.1 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.0 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.0 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.1 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.0 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 1.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.3 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.0 | 0.1 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.0 | 0.4 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.0 | 0.1 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.0 | 0.0 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.0 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.0 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 1.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.0 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.0 | 0.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.5 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.1 | GO:1902170 | cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
0.0 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 1.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.3 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.3 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.0 | 0.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.3 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.0 | 0.2 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 1.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.8 | GO:0032355 | response to estradiol(GO:0032355) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.1 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.0 | 0.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.0 | 0.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 1.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.2 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.0 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.2 | GO:0072012 | glomerulus vasculature development(GO:0072012) |
0.0 | 0.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.0 | 0.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 0.7 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.3 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.4 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.3 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.7 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.3 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.9 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 1.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.0 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 1.0 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.1 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.3 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.0 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.8 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.0 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.2 | GO:0045005 | replication fork processing(GO:0031297) DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.0 | 0.3 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.7 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.2 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.0 | 0.1 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.2 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.0 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.8 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.6 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 1.0 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 1.0 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.0 | 0.2 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.0 | 0.0 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.0 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.0 | 0.0 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.0 | 0.9 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.5 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 1.6 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.1 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.0 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:1903514 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.0 | 0.1 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 0.0 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.0 | 0.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.8 | GO:0045088 | regulation of innate immune response(GO:0045088) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.0 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.1 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.1 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 0.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.1 | GO:0050000 | chromosome localization(GO:0050000) |
0.0 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.3 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.3 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 0.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.4 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.0 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.0 | 0.1 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.0 | 0.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.4 | GO:0098840 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.0 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.0 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.0 | 0.0 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.0 | 0.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.0 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.0 | 0.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.0 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.5 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.3 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.3 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.0 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.4 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.0 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.0 | 0.0 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.0 | 0.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.1 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.2 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.4 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.3 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.0 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.0 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.0 | 0.0 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.0 | 0.0 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.6 | GO:0060348 | bone development(GO:0060348) |
0.0 | 0.0 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
0.0 | 0.0 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.0 | 0.0 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.0 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.1 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0032602 | chemokine production(GO:0032602) |
0.0 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0061384 | heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.3 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.0 | 0.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.1 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.3 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.6 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.0 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 0.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.0 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.0 | 0.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.3 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.0 | 0.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.0 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.0 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.2 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.0 | 0.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.0 | 0.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.1 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.0 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.1 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.0 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.2 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.0 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.0 | GO:0046636 | negative regulation of alpha-beta T cell activation(GO:0046636) |
0.0 | 0.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.0 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.0 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.0 | 0.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.0 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.0 | 0.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.0 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.1 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.2 | GO:0001824 | blastocyst development(GO:0001824) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 4.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.7 | 5.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.6 | 3.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 1.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 2.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 1.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 3.2 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 1.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 1.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 2.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 1.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 0.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 3.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 0.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 1.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 3.8 | GO:0031430 | M band(GO:0031430) |
0.3 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 3.4 | GO:0043034 | costamere(GO:0043034) |
0.3 | 14.3 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 1.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 3.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 1.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 4.6 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.2 | 2.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 1.9 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 1.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.6 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 1.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 3.2 | GO:0031672 | A band(GO:0031672) |
0.2 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 2.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.7 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.2 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 1.2 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 2.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 1.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 1.1 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 5.1 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.4 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 7.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.8 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 5.6 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 1.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 7.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.7 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 2.3 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.5 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 1.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 1.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.8 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 4.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.4 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.1 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.1 | 1.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 2.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 1.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.2 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 2.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.5 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 1.6 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.9 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.8 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 2.6 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 1.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 19.4 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.8 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.8 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.3 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 0.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.7 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 1.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 4.0 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.2 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 1.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.8 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.1 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.1 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 2.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.8 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.3 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 3.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.3 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 3.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 1.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 1.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.6 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 2.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 1.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 2.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 8.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 2.0 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.5 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 1.5 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.2 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.0 | 1.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.6 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 1.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 1.3 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 1.4 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 2.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 1.3 | GO:0016605 | PML body(GO:0016605) |
0.0 | 6.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 1.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 1.0 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 1.0 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.9 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 1.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.8 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.0 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 7.5 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 1.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.3 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.0 | 1.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.0 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 1.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.8 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.9 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 1.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 3.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 1.5 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 23.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.0 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 0.4 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.0 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.0 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 6.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0097470 | ribbon synapse(GO:0097470) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.0 | 4.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.8 | 2.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.6 | 1.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 1.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.6 | 3.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.5 | 1.4 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.5 | 2.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 1.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 2.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 4.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 1.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 1.1 | GO:0018596 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.3 | 0.3 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.3 | 1.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 1.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 2.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 1.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 5.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.3 | 1.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 1.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.9 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.3 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 0.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 4.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 0.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 3.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 1.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 1.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 0.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 0.8 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 0.8 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 2.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 0.7 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 1.2 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 3.6 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.9 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 2.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 0.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 1.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 2.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 1.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 1.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 0.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 2.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.9 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 1.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.2 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.2 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 1.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 1.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 1.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 1.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 3.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 0.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 1.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 2.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.6 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.2 | 2.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.9 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 1.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.5 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 1.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.9 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.2 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 2.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 1.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 2.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.4 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 1.2 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.1 | 0.3 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 4.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.7 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 2.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 1.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 1.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 1.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.5 | GO:0043830 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.1 | 1.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 1.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 1.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.5 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 1.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.5 | GO:0035276 | ethanol binding(GO:0035276) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.2 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.5 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 1.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 5.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 1.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 1.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.9 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 0.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 4.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 1.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 1.1 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.3 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.1 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 2.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 1.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.9 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 1.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 5.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 1.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 3.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.3 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 1.6 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 1.7 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 1.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.8 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 1.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 1.0 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.6 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.1 | 0.3 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 1.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 1.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.3 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.9 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 2.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.8 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.2 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.5 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 3.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.9 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 1.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.2 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.1 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 1.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.4 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 1.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 3.1 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 1.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.3 | GO:0052849 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.0 | 1.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.4 | GO:0018446 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 1.7 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.2 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.0 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 1.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.0 | 0.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 1.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.3 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 1.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.0 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 2.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.6 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.2 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 0.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 1.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 1.2 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 6.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 3.8 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 1.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.9 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 1.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 9.0 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 1.4 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.4 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.9 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 4.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.7 | GO:0019838 | growth factor binding(GO:0019838) |
0.0 | 0.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.2 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.2 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.0 | 1.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 3.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.4 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.0 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.7 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 2.5 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.5 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 1.2 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 1.3 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 1.5 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.3 | GO:0043908 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) retinyl-palmitate esterase activity(GO:0050253) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 7.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 8.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 8.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 2.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 9.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 1.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 2.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 9.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 3.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 1.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 1.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 2.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 4.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 2.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 6.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 3.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 2.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 3.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 4.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.2 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 2.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 3.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 3.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 2.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 2.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 3.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 3.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 4.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 2.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.5 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 3.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 7.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 7.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 10.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 1.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.7 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 0.5 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.3 | 9.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 2.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 3.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 4.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 2.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 0.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.2 | 2.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 1.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 3.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 1.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 1.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 1.9 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 1.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 0.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 1.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 1.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 0.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 1.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 3.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 3.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 0.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 14.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 6.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 6.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 4.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 7.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.7 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 2.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.6 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.1 | 1.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 2.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.7 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 1.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 1.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 0.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 2.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 1.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 6.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 4.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 1.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 6.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 1.4 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 3.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 5.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.4 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 1.6 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.0 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.0 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 1.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 2.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.1 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.0 | 1.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 1.2 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 1.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 4.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.8 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 1.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 1.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.1 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.0 | 0.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.1 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.0 | 0.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.0 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.2 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |